Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to
assemble and peer-review its pathway modules. The integration of ORCID within Reactome
enables us to meet a key challenge with authoring, curating and reviewing biological
information by incentivizing and crediting the external experts that contribute their
expertise and time to the Reactome curation process. More information is available at
ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please
forward this information to us and we will update your Reactome pathway records.
Details on Person Itoh, Fumiaki
| Class:Id | Person:207105 |
|---|
| _displayName | Itoh, Fumiaki |
|---|
| _timestamp | 2017-03-07 20:41:40 |
|---|
| created | [InstanceEdit:205608] Williams, MG, 2007-03-27 14:11:11 |
|---|
| firstname | Fumiaki |
|---|
| initial | F |
|---|
| modified | [InstanceEdit:8981429] D'Eustachio, Peter, 2017-03-07 |
|---|
| surname | Itoh |
|---|
| (author) | [LiteratureReference:208195] The FYVE domain in Smad anchor for receptor activation (SARA) is sufficient for localization of SARA in early endosomes and regulates TGF-beta/Smad signalling
[LiteratureReference:429653] SLC5A9/SGLT4, a new Na+-dependent glucose transporter, is an essential transporter for mannose, 1,5-anhydro-D-glucitol, and fructose
[LiteratureReference:9728535] Sergliflozin, a novel selective inhibitor of low-affinity sodium glucose cotransporter (SGLT2), validates the critical role of SGLT2 in renal glucose reabsorption and modulates plasma glucose level
[LiteratureReference:9734479] Fibrate and statin synergistically increase the transcriptional activities of PPARalpha/RXRalpha and decrease the transactivation of NFkappaB |
|---|
|
[Change default viewing format]
|
No pathways have been reviewed or authored by Itoh, Fumiaki (207105)
